000 | 01062 a2200325 4500 | ||
---|---|---|---|
005 | 20250514012024.0 | ||
264 | 0 | _c20011018 | |
008 | 200110s 0 0 eng d | ||
022 | _a0140-6736 | ||
024 | 7 |
_a10.1016/S0140-6736(01)06149-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTobin, G R | |
245 | 0 | 0 |
_aHand transplantation follow-up. _h[electronic resource] |
260 |
_bLancet (London, England) _cSep 2001 |
||
300 |
_a1018 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
650 | 0 | 4 | _aHand Transplantation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aGranger, D K | |
700 | 1 | _aBreidenbach, W C | |
773 | 0 |
_tLancet (London, England) _gvol. 358 _gno. 9286 _gp. 1018 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(01)06149-9 _zAvailable from publisher's website |
999 |
_c11513612 _d11513612 |